title: In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey.
abstract: The activity of amoxycillin/clavulanate (Augmentin) and ticarcillin/ clavulanate (Timentin) was tested against 351 strict anaerobic clinical isolates collected from September 1993 to April 1994 in eight Belgian university hospitals and compared with that of 8 other antibiotics using the NCCLS reference agar dilution procedure. Production of beta-lactamase was detected by the nitrocefin test in 48% of the isolates. At NCCLS-recommended breakpoints, more than 90% of isolates were susceptible to amoxycillin/clavulanate, ticarcillin/clavulanate, piperacillin/tazobactam, imipenem, chloramphenicol and metronidazole but only 77%, 72% and 48% to cefoxitin, clindamycin and penicillin, respectively. In comparison with the results of a similar survey conducted in 1987 no major changes in susceptibility were observed except for the susceptibility to clindamycin that declined from 83% to 72% overall, and from 83% to 66% in the B. fragilis group. Furthermore one isolate of Clostridium clostridioforme was found produce beta-lactamase and few B. fragilis group isolates showed reduced susceptibility to metronidazole.
authors.affiliation: Department of Microbiology, Academisch Ziekenhuis Vrije Universteit, Brussel.
authors.forename: D
authors.initials: D
authors.lastname: Pierard
authors.forename: A
authors.initials: A
authors.lastname: De Meyer
authors.forename: P
authors.initials: P
authors.lastname: Rosseel
authors.forename: M
authors.initials: M
authors.lastname: Van Cauwenbergh
authors.forename: M J
authors.initials: MJ
authors.lastname: Struelens
authors.forename: M
authors.initials: M
authors.lastname: Delmee
authors.forename: H
authors.initials: H
authors.lastname: Goossens
authors.forename: G
authors.initials: G
authors.lastname: Claeys
authors.forename: Y
authors.initials: Y
authors.lastname: Glupczynski
authors.forename: L
authors.initials: L
authors.lastname: Verbist
authors.forename: P
authors.initials: P
authors.lastname: Melin
authors.forename: S
authors.initials: S
authors.lastname: Lauwers
mesh_terms: D000658:Amoxicillin / Q000494:pharmacology; D019980:Amoxicillin-Potassium Clavulanate Combination; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001421:Bacteria, Anaerobic / Q000187:drug effects*; D002969:Clavulanic Acids / Q000494:pharmacology; D004359:Drug Therapy, Combination / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D013982:Ticarcillin / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin; C043215:ticarcillin-clavulanic acid; D013982:Ticarcillin